Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
:max_bytes(150000):strip_icc()/Booster-Shot-GettyImages-1362497127-e10ca9b1e3e5424db126022a8dc254bf.jpg "How Effective Are the Bivalent Boosters? CDC Shares New Data")
How Effective Are the Bivalent Boosters? CDC Shares New Data
Bivalent COVID-19 boosters gave seniors 80% better protection: CDC | ABCNL - YouTube
Updated boosters add limited protection against Covid-19 illness, first real-world study shows | CNN
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News
Bivalent mRNA booster effective, 'essential' for older adults
Why payers should be preparing now for new COVID-19 boosters
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
The Updated COVID Boosters Could Have Been Better | MedPage Today
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
New Omicron-specific vaccines offer similar protection to existing boosters
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
